Thông tin cho nhân viên y tế
Thuốc mới và thông tin từ Drugs.com
- September 30, 2024 — Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic conditions, and Formycon AG, a leading…
- Paris and Tarrytown, NY, September 27, 2024. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an…
- ARLINGTON HEIGHTS, Ill.–(BUSINESS WIRE) September 27, 2024 –GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Flyrcado (flurpiridaz F 18) injection, a first of its kind positron…
- PRINCETON, N.J.–(BUSINESS WIRE)–26 September 2024– Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride), an oral medication for the treatment of…
- On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and pediatric patients 2 years of age and older with advanced or metastatic medullary thyroid cancer…
- Cambridge, UK –26 September 2024–AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the treatment of adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer…
- THURSDAY, Oct. 3, 2024 — For older stroke survivors, incident stroke is associated with acute and accelerated long-term cognitive decline, according to a study published online Oct. 2 in JAMA Network Open.Jessica W. Lo, from the University of New…
- THURSDAY, Oct. 3, 2024 — Clinically diagnosed depression increased from 2017 to 2021 in children, adolescents, and young adults, with a higher increase during the pandemic, according to a study published online Oct. 1 in JAMA Network Open.Anny H…
- THURSDAY, Oct. 3, 2024 — Counterfeit medications from online pharmacies pose significant risks to patients, including overdose and death, according to a warning issued by the U.S. Centers for Disease Control and Prevention.The warning follows a…
- THURSDAY, Oct. 3, 2024 — Fatal falls incur significantly higher costs than fatal firearm injuries among those aged older than 45 years, according to a study published online Oct. 1 in Trauma Surgery & Acute Care Open.Bardiya Zangbar, M.D…
- THURSDAY, Oct. 3, 2024 — Rheumatoid arthritis (RA) is associated with higher health care expenditures and suboptimal quality of life in U.S. adults, according to a study published online Aug. 6 in ACR Open Rheumatology. Yinan Huang, Ph.D., from…
- THURSDAY, Oct. 3, 2024 — Harmful diagnostic errors (DEs) occur in an estimated one of every 14 hospitalized general medicine patients, according to a study published online Oct. 1 in BMJ Quality & Safety. Anuj K. Dalal, M.D., from Brigham and…
Thông tin từ The Pharma Letter
- The UK’s new 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year.
- A Spanish framework for medical cannabis usage is finally on the way, Cannabis Health reports.
- Trevi Therapeutics has announced significant milestones in its clinical programs for Haduvio (nalbuphine), an investigational therapy aimed at treating chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC).
- Italian pharma major Recordati saw its shares rise more than 5% to 52.00 euros in early trading, as it announced a deal to expand its portfolio of marketed rare disease medicines.
- Paris-based asset manager Kurma Partners has raised 140 million euros ($154 million), successfully completing the first closing of Biofund IV
- The European Medicines Agency’s pharmacovigilance committee, PRAC, has started a review of medicines containing finasteride and dutasteride following concerns regarding suicidal ideation (suicidal thoughts) and behaviors.
Thông tin từ BioPharmaDive
- The gene editing company is selling to DRI Healthcare Trust future license fees that are owed to it under an agreement with Vertex last year.
- Having already been on a winding journey, Enjaymo, which Sanofi acquired through a 2018 buyout of Bioverativ, is now headed to Recordati as part of a deal announced Friday.
- Bristol Myers' immunotherapy can now be used before and after surgery in the U.S. Elsewhere, J&J, Bayer, Bristol Myers Squibb and Pfizer are trimming staff.
- An experimental Alzheimer’s therapy from Cassava Sciences is still being tested in two Phase 3 studies, even as the company has come under scrutiny.
- The agency will offer earlier meetings with drugmakers as well as solicit more patient feedback on the process.
- Removal of Lilly’s in-demand drugs from the FDA’s shortage list ramps up pressure on the companies selling compounded counterparts.
Thông tin từ STAT News
- Exact Sciences won approval on Friday for an improved version of a stool-based screening test for colon cancer
- Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and…
- Ahead of the BIOSECURE Act, WuXi AppTec is in talks to sell its Philadelphia-based cell and gene therapy unit, and WuXi Biologics is exploring whether there’s interest in purchasing its…
- Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Today’s item on bacterial outbreaks linked to hospital ice machines reminded me…
- The adult obesity rate in the U.S. fell by around 2% between 2020 and 2023, according to new data.
- The CEO of the American Heart Association urges Congress to prevent deaths from cardiac arrest by passing the HEARTS Act.
Thông tin từ Nature Review Drug Discovery
- Nature Reviews Drug Discovery, Published online: 04 October 2024; doi:10.1038/s41573-024-01042-yFollowing the success of the COVID-19 vaccines, mRNA vaccines have now entered development for a wide range of infectious diseases. This Review discusses mRNA vaccine design considerations, delivery strategies and mechanisms of action, assessing mRNA vaccines currently in development for various viruses, bacteria and parasites. The […]
- Nature Reviews Drug Discovery, Published online: 03 October 2024; doi:10.1038/d41573-024-00165-6A viral–lipid hybrid delivery system for genetic therapies
- Nature Reviews Drug Discovery, Published online: 02 October 2024; doi:10.1038/d41573-024-00153-wTwo decades of new drug approvals in Japan
- Nature Reviews Drug Discovery, Published online: 01 October 2024; doi:10.1038/d41573-024-00164-7FDA approves first monoclonal antibody for COPD
- Nature Reviews Drug Discovery, Published online: 30 September 2024; doi:10.1038/s41573-024-01033-zWith ageing global populations, cellular senescence is gaining increasing attention as a therapeutic target. In their Review, Orr and colleagues discuss ongoing research into senescence in the central nervous system, including promising targets and drugs in development that aim to clear senescent cells or modulate their […]
- Nature Reviews Drug Discovery, Published online: 27 September 2024; doi:10.1038/d41573-024-00162-9FDA approves first two drugs for rare Niemann–Pick disease